极早产儿无出血性脑室扩大与神经发育及行为结局
这项多中心纵向观察研究纳入2006至2011年出生、胎龄小于27周的极早产儿,比较无出血性脑室扩大与正常颅脑超声者的结局。校正混杂因素后,脑室扩大与神经发育损害、认知损害、中重度脑瘫及死亡/神经发育损害复合结局的 odds 升高相关,但单纯死亡和行为结局无差异。
要点
- 无出血性脑室扩大与极早产儿神经发育损害风险升高相关(OR 3.07)。
- 认知损害(OR 3.23)和中重度脑瘫(OR 3.68)风险亦升高。
- 死亡/神经发育损害复合结局风险升高(OR 2.17),但单纯死亡无差异。
核心结论
- 无出血性脑室扩大与极早产儿神经发育损害风险升高相关。
研究设计与样本
- 纵向观察研究,纳入16个中心胎龄小于27周且36周经后年龄前完成颅脑超声的极早产儿。
主要发现
- 4193例有超声数据的新生儿中,无出血性脑室扩大300例(7%),正常颅脑超声3045例(73%)。
- 脑室扩大组神经发育损害OR 3.07(95%CI 2.13-4.43),认知损害OR 3.23(95%CI 2.09-4.99)。
- 中重度脑瘫OR 3.68(95%CI 2.08-6.51),死亡/神经发育损害OR 2.17(95%CI 1.62-2.91)。
- 单纯死亡OR 1.09(95%CI 0.76-1.57),行为结局无差异。
关键数值与推荐
- 神经发育损害定义为Bayley婴幼儿发育量表III认知评分小于70、中重度脑瘫、粗大运动功能分类系统≥2级、视力损害或听力损害。
临床怎么用
- 对存在无出血性脑室扩大的极早产儿应加强神经发育随访与早期干预评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Studies of cranial ultrasonography and early childhood outcomes among cohorts of extremely preterm neonates have linked periventricular-intraventricular hemorrhage and cystic periventricular leukomalacia with adverse neurodevelopmental outcomes. However, the association between nonhemorrhagic ventriculomegaly and neurodevelopmental and behavioral outcomes is not fully understood. OBJECTIVE: To characterize the outcomes of extremely preterm neonates younger than 27 weeks' gestational age who experienced nonhemorrhagic ventriculomegaly that was detected prior to 36 weeks' postmenstrual age. DESIGN, SETTING, AND PARTICIPANTS: This longitudinal observational study was conducted at 16 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Infants born prior to 27 weeks' gestational age in any network facility between July 1, 2006, and June 30, 2011, were included if they had a cranial ultrasonogram performed prior to 36 weeks' postmenstrual age. Comparisons were made between those with ventriculomegaly and those with normal cranial sonograms. Data analysis was completed from August 2013 to August 2017. MAIN OUTCOMES AND MEASURES: The main outcome was neurodevelopmental impairment, defined as a Bayley Scales of Infant and Toddler Development III cognitive score less than 70, moderate/severe cerebral palsy, a Gross Motor Function Classification System score of level 2 or more, vision impairment, or hearing impairment. Secondary outcomes included Bayley Scales of Infant and Toddler Development III subscores, components of neurodevelopmental impairment, behavioral outcomes, and death/neurodevelopmental impairment. Logistic regression was used to evaluate the association of ventriculomegaly with adverse outcomes while controlling for potentially confounding variables and center differences as a random effect. Linear regression was used similarly for continuous outcomes. RESULTS: Of 4193 neonates with ultrasonography data, 300 had nonhemorrhagic ventriculomegaly (7%); 3045 had normal cranial ultrasonograms (73%), 775 had periventricular-intraventricular hemorrhage (18.5%), and 73 had cystic periventricular leukomalacia (1.7%). Outcomes were available for 3008 of 3345 neonates with ventriculomegaly or normal scans (90%). Compared with normal cranial ultrasonograms, ventriculomegaly was associated with lower gestational age, male sex, and bronchopulmonary dysplasia, late-onset sepsis, meningitis, necrotizing enterocolitis, and stage 3 retinopathy of prematurity. After adjustment, neonates with ventriculomegaly had higher odds of neurodevelopmental impairment (odds ratio [OR], 3.07; 95% CI, 2.13-4.43), cognitive impairment (OR, 3.23; 95% CI, 2.09-4.99), moderate/severe cerebral palsy (OR, 3.68; 95% CI, 2.08-6.51), death/neurodevelopmental impairment (OR, 2.17; 95% CI, 1.62-2.91), but not death alone (OR, 1.09; 95% CI, 0.76-1.57). Behavioral outcomes did not differ. CONCLUSIONS AND RELEVANCE: Nonhemorrhagic ventriculomegaly is associated with increased odds of neurodevelopmental impairment among extremely preterm neonates.
引用
- Pappas A, Adams-Chapman I, Shankaran S, et al. Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular Hemorrhage. JAMA Pediatr. 2018. PMID: 29181530. doi:10.1001/jamapediatrics.2017.3545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。